Weekly Life Science News Round Up: 18th – 22nd April
A round-up of the latest news from the Life Science industry; including Clinical Research, Drug Development, Cell and Gene Therapy and more news from 18th – 22nd April.
Hikma Pharmaceuticals announces that it has completed its acquisition of Custopharm Inc. from Water Street Healthcare Partners (‘Water Street’).
Panthera Biosciences has secured £10 million of investment from BGF and Gresham House Ventures, the latter investing on behalf of the Baronsmead VCTs.
Evaluate and Treehill Partners announces that they have entered into a global strategic collaboration to combine Evaluate’s industry leading data analytics and strategic consulting with Treehill’s world class transaction advisory and execution services in healthcare.
Thermo Fisher Scientific celebrates the opening of its new single-use technology manufacturing site in Ogden, Utah.
Boehringer Ingelheim and Eli Lilly and Company announces the launch of Hear Your Heart, a health initiative that empowers women with heart failure to prioritise their care.
PacBio announces an expanded research collaboration with Children’s Mercy Kansas City to use the multi-omics capabilities of PacBio’s Sequel IIe system in the study of genetic disease.
BenevolentAI and Drugs for Neglected Disease initiative (DNDi) announces they have begun a joint research project to tackle dengue, one of the world’s most prevalent infectious diseases.
X-Chem today announces the availability of XD3 – X-Chem’s Dynamic Drug Discovery ecosystem for biopharma partners and clients.
Labcorp is collaborating with Xcell Biosciences to advance critical work that helps clients effectively bring innovative cell and gene therapies to market.
Kite, a Gilead company, announces the U.S. Food and Drug Administration (FDA) has approved commercial production at the company’s new CAR T-cell therapy manufacturing facility in Frederick, Maryland.
Fast-growing contract development and manufacturing organisation (CDMO) BORA Pharmaceuticals, has announced a planned investment of $10 million to expand its Oral Solid Dose capabilities across facilities in Zhuhan, Taiwan and Mississauga, Ontario.
BioXcel Therapeutics announces the formation of wholly-owned subsidiary OnkosXcel Therapeutics to develop transformative medicines in oncology.
EVERSANA announces a strategic partnership to create a direct-to-patient platform that will transform the patient experience to help accelerate access to therapies worldwide.
Advanced Clinical announces its continued expansion into Europe with the opening of a new office in Zug, Switzerland.
The PPD clinical research business of Thermo Fisher Scientific and Moderna, whose pioneering mRNA vaccine for COVID has been administered to hundreds of millions globally, were named ‘Clinical Research Team of the Year’ during the 2021 Citeline Awards.